023 Risk Stratification Using CHA2DS2-VASc and CHADS2 Scores in Patients With Chronic Atherosclerotic Cardiovascular Disease Receiving Aspirin With or Without Rivaroxaban: An Analysis of the COMPASS Trial Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Sen, J
  • Tonkin, A
  • Varigos, J
  • Fonguh, S
  • Berkowitz, S
  • Yusuf, S
  • Verhamme, P
  • Vanassche, T
  • Anand, Sonia
  • Fox, K
  • Eikelboom, J
  • Amerena, J

publication date

  • 2020